Environmental toxicants and the developing immune system: A missing link in the global battle against infectious disease?

Reproductive Toxicology

Volumn 31, Issue 3, 2011, Pages 327-336

  Winans, Bethany ^a   Humble, Michael C ^b   Lawrence, B Paige ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Fetal basis of adult disease; Immune development; Infectious disease susceptibility; Maternal exposure; Pollutants

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4,4' ISOPROPYLIDENEDIPHENOL; ARSENIC; CIGARETTE SMOKE; DIOXIN; ENVIRONMENTAL CHEMICAL; METAL; PERFLUORONONANOIC ACID; PERFLUOROOCTANESULFONIC ACID; PESTICIDE; PHTHALIC ACID; POLYCHLORINATED BIPHENYL; POLYCYCLIC AROMATIC HYDROCARBON; SOLVENT;

CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CAUSE OF DEATH; CHILD DEVELOPMENT; DISEASE PREDISPOSITION; EARLY LIFE STRESS; ENVIRONMENTAL EXPOSURE; GESTATION PERIOD; HEALTH HAZARD; HUMAN; IMMUNE SYSTEM; INFECTION; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INFECTION SENSITIVITY; NONHUMAN; REVIEW;

ADULT; COMMUNICABLE DISEASES; DISEASE SUSCEPTIBILITY; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; IMMUNE SYSTEM; MATERNAL EXPOSURE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

ANIMALIA;

EID: 79953751613     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.09.004     Document Type: Review

References (150)

1. World Health Organization. The global burden of disease: 2004 update. 2008. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html.
2. Hill A.V.S. The Immunogenetics of human infectious diseases. Annual Review of Immunology 1998, 16:593-617.
3. Weiskopf D., Weinberger B., Grubeck-Loebenstein B. The aging of the immune system. Transplant International 2009, 22:1041-1050.
4. Colosio C., Birindelli S., Corsini E., Galli C.L., Maroni M. Low level exposure to chemicals and immune system. Toxicology and Applied Pharmacology 2005, 207:320-328.
5. Spannhake E.W., Reddy S.P., Jacoby D.B., Yu X.Y., Saatian B., Tian J. Synergism between rhinovirus infection and oxidant pollutant exposure enhances airway epithelial cell cytokine production. Environmental Health Perspectives 2002, 110:665-670.
6. Stancek D., Kosecka G., Oltman M., Keleova A., Jahnova E. Links between prolonged exposure to xenobiotics, increased incidence of hepatopathies, immunological disturbances and exacerbation of latent Epstein-Barr virus infections. International Journal of Immunopharmacology 1995, 17:321-328.
7. Singh V. The burden of pneumonia in children: an Asian perspective. Paediatric Respiratory Reviews 2005, 6:88-93.
8. Stampfli M.R., Anderson G.P. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nature Reviews Immunology 2009, 9:377-384.
9. Gluckman P.D., Hanson M.A. Living with the past: evolution, development, and patterns of disease. Science 2004, 305:1733-1736.
10. Edwards T.M., Myers J.P. Environmental exposures and gene regulation in disease etiology. Cien Saude Colet 2008, 13:269-281.
11. Gluckman P.D., Hanson M.A., Cooper C., Thornburg K.L. Effect of in utero and early life conditions on adult health and disease. New England Journal of Medicine 2008, 359:61-73.
12. Barker D.J. The origins of the developmental origins theory. Journal of Internal Medicine 2007, 261:412-417.
13. Dietert R.R. Developmental immunotoxicology: focus on health risks. Chemical Research in Toxicology 2009, 22:17-23.
14. Dzierzak E., Medvinsky A. Mouse embryonic hematopoiesis. Trends in Genetics 1995, 11:359-366.
15. Robin C., Ottersbach K., de Bruijn M., Ma X., van der Horn K., Dzierzak E. Developmental origins of hematopoietic stem cells. Oncology Research 2003, 13:315-321.
16. Zhu J., Emerson S.G. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene 2002, 21:3295-3313.
17. Kuper H., Adami H., Trichopoulos D. Infections as a major preventable cause of human cancer. Journal of Internal Medicine 2000, 248:171-183.
18. World Health Organization. World Cancer Report. 2008. http://www.who.int/cancer/publications/en/.
19. Holladay S.D., Smialowicz R.J. Development of the murine and human immune system: differential effects of immunotoxicants depend on time of exposure. Environmental Health Perspectives 2000, 108:463.
20. Abraham K., Papke O., Gross A., Kordonouri O., Wiegand S., Wahn U., et al. Time course of PCDD/PCDF/PCB concentrations in breast-feeding mothers and their infants. Chemosphere 1998, 37:1731-1741.
21. Guvenius D.M., Aronsson A., Ekman-Ordeberg G., Bergman A., Noren K. Human prenatal and postnatal exposure to polybrominated diphenyl ethers, polychlorinated biphenyls, polychlorobiphenylols, and pentachlorophenol. Environmental Health Perspectives 2003, 111:1235-1241.
22. Zanieri L., Galvan P., Checchini L., Cincinelli A., Lepri L., Donzelli G.P., et al. Polycyclic aromatic hydrocarbons (PAHs) in human milk from Italian women: influence of cigarette smoking and residential area. Chemosphere 2007, 67:1265-1274.
23. Nguyen L.P., Bradfield C.A. The search for endogenous activators of the aryl hydrocarbon receptor. Chemical Research in Toxicology 2008, 21:102-116.
24. Heilmann C., Grandjean P., Weihe P., Nielsen F., Budtz-Jorgensen E. Reduced antibody responses to vaccinations in children exposed to polychlorinated biphenyls. PLoS Medicine 2006, 3:e311.
25. Weisglas-Kuperus N., Patandin S., Berbers G.A., Sas T.C., Mulder P.G., Sauer P.J., et al. Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environmental Health Perspectives 2000, 108:1203.
26. Glynn A., Thuvander A., Aune M., Johannisson A., Darnerud P., Ronquist G., et al. Immune cell counts and risks of respiratory infections among infants exposed pre- and postnatally to organochlorine compounds: a prospective study. Environmental Health 2008, 7:62.
27. Dallaire F., Dewailly E., Muckle G., Vezina C., Jacobson S.W., Jacobson J.L., et al. Acute infections and environmental exposure to organochlorines in Inuit infants from Nunavik. Environmental Health Perspectives 2004, 112:1359-1363.
28. Dewailly E., Ayotte P., Bruneau S., Gingras S., Belles-Isles M., Roy R. Susceptibility to infections and immune status in Inuit infants exposed to organochlorines. Environmental Health Perspectives 2000, 108:205-211.
29. Jedrychowski W., Galas A., Pac A., Flak E., Camman D., Rauh V., et al. Prenatal ambient air exposure to polycyclic aromatic hydrocarbons and the occurrence of respiratory symptoms over the first year of life. European Journal of Epidemiology 2005, 20:775-782.
30. Weisglas-Kuperus N., Vreugdenhil H.J., Mulder P.G. Immunological effects of environmental exposure to polychlorinated biphenyls and dioxins in Dutch school children. Toxicology Letters 2004, 149:281-285.
31. Guo Y.L., Lambert G.H., Hsu C.C., Hsu M.M. Yucheng: health effects of prenatal exposure to polychlorinated biphenyls and dibenzofurans. International Archives of Occupational and Environmental Health 2004, 77:153-158.
32. Vos J.G., Moore J.A. Suppression of cellular immunity in rats and mice by maternal treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. International Archives of Allergy and Applied Immunology 1974, 47:777-794.
33. Faith R.E., Moore J.A. Impairment of thymus-dependent immune functions by exposure of the developing immune system to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Journal of Toxicology and Environmental Health 1977, 3:451-464.
34. Holladay S.D., Lindstrom P., Blaylock B.L., Comment C.E., Germolec D.R., Heindell J.J., et al. Perinatal thymocyte antigen expression and postnatal immune development altered by gestational exposure to tetrachlorodibenzo-p-dioxin (TCDD). Teratology 1991, 44:385-393.
35. Gehrs B.C., Riddle M.M., Williams W.C., Smialowicz R.J. Alterations in the developing immune system of the F344 rat after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. II. Effects on the pup and the adult. Toxicology 1997, 122:229-240.
36. Gehrs B., Smialowicz R. Persistent suppression of delayed-type hypersensitivity in adult F344 rats after perinatal exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin* 1. Toxicology 1999, 134:79-88.
37. Fine J., Gasiewicz T., Silverstone A. Lymphocyte stem cell alterations following perinatal exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Molecular Pharmacology 1989, 35:18.
38. Blaylock B., Holladay S., Comment C., Heindel J., Luster M. Exposure to tetrachlorodibenzo-p-dioxin (TCDD) alters fetal thymocyte maturation. Toxicology and Applied Pharmacology 1992, 112:207-213.
39. Camacho I., Nagarkatti M., Nagarkatti P. Evidence for induction of apoptosis in T cells from murine fetal thymus following perinatal exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicological Sciences 2004, 78:96.
40. Vorderstrasse B., Cundiff J.A., Lawrence B.P. Potent aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs the cell-mediated immune response to infection with Influenza A virus, but enhances elements of innate immunity. Journal of Immunotoxicology 2004, 1:103-112.
41. Sugita-Konishi Y., Kobayashi K., Naito H., Miura K., Suzuki Y. Effect of lactational exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin on the susceptibility to Listeria infection. Bioscience, Biotechnology, and Biochemistry 2003, 67:89-93.
42. Vorderstrasse B.A., Cundiff J.A., Lawrence B.P. A dose-response study of the effects of prenatal and lactational exposure to TCDD on the immune response to influenza a virus. Journal of Toxicology and Environmental Health Part A 2006, 69:445-463.
43. Hogaboam J.P., Moore A.J., Lawrence B.P. The aryl hydrocarbon receptor affects distinct tissue compartments during ontogeny of the immune system. Toxicological Sciences 2008, 102:160-170.
44. Nagayama J., Tsuji H., Iida T., Nakagawa R., Matsueda T., Hirakawa H., et al. Immunologic effects of perinatal exposure to dioxins. PCBs and organochlorine pesticides in Japanese infants. Chemosphere 2007, 67:S393-S398.
45. ten Tusscher G.W., Steerenberg P.A., van Loveren H., Vos J.G., Borne A.E., Westra M., et al. Persistent hematologic and immunologic disturbances in 8-year-old Dutch children associated with perinatal dioxin exposure. Environmental Health Perspectives 2003, 111:1519-1523.
46. Weisglas-Kuperus N., Sas T.C., Koopman-Esseboom C., Zwan C.W., De Ridder M.A., Beishuizen A., et al. Immunologic effects of background prenatal and postnatal exposure to dioxins and polychlorinated biphenyls in Dutch infants. Pediatric Research 1995, 38:404-410.
47. Hertz-Picciotto I., Park H.Y., Dostal M., Kocan A., Trnovec T., Sram R. Prenatal exposures to persistent and non-persistent organic compounds and effects on immune system development. Basic & Clinical Pharmacology & Toxicology 2008, 102:146-154.
48. Park H.Y., Hertz-Picciotto I., Petrik J., Palkovicova L., Kocan A., Trnovec T., et al. exposure and thymus size at birth in neonates in Eastern Slovakia. Environmental Health Perspectives 2008, 116:104-109.
49. Jusko T.A., De Roos A.J., Schwartz S.M., Paige Lawrence B., Palkovicova L., Nemessanyi T., et al. A cohort study of developmental polychlorinated biphenyl (PCB) exposure in relation to post-vaccination antibody response at 6-months of age. Environmental Research 2010, 110:388-395.
50. Kelvin E.A., Edwards S., Jedrychowski W., Schleicher R.L., Camann D., Tang D., et al. Modulation of the effect of prenatal PAH exposure on PAH-DNA adducts in cord blood by plasma antioxidants. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol. 18 2009, 2262-2268.
51. Wang S., Chanock S., Tang D., Li Z., Jedrychowski W., Perera F.P. Assessment of interactions between PAH exposure and genetic polymorphisms on PAH-DNA adducts in African American, Dominican, and Caucasian mothers and newborns. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol. 17 2008, 405-413.
52. Perera F., Tang D., Rauh V., Lester K., Tsai W., Tu Y., et al. Relationships among polycyclic aromatic hydrocarbon DNA adducts, proximity to the World Trade Center, and effects on fetal growth. Environmental Health Perspectives 2005, 113:1062.
53. National Research Center for Women and Families. Issue brief: smoking is a Women's Health Issue. 2004. http://www.center4research.org/.
54. American Cancer Society. Women and Smoking. 2009. http://www.cancer.org/docroot/ped/content/ped_10_2x_women_and_smoking.asp.
55. Jaakkola J.J., Kosheleva A.A., Katsnelson B.A., Kuzmin S.V., Privalova L.I., Spengler J.D. Prenatal and postnatal tobacco smoke exposure and respiratory health in Russian children. Respiratory Research 2006, 7:48.
56. Le Souef P.N. Adverse effects of maternal smoking during pregnancy on innate immunity in infants. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology 2006, 28:675-677.
57. DiFranza J.R., Aligne C.A., Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics 2004, 113:1007.
58. Bradley J.P., Bacharier L.B., Bonfiglio J., Schechtman K.B., Strunk R., Storch G., et al. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 2005, 115:e7-14.
59. Cheraghi M., Salvi S. Environmental tobacco smoke (ETS) and respiratory health in children. European Journal of Pediatrics 2009, 168:897-905.
60. Noakes P.S., Hale J., Thomas R., Lane C., Devadason S.G., Prescott S.L. Maternal smoking is associated with impaired neonatal toll-like-receptor-mediated immune responses. European Respiratory Journal 2006, 28:721-729.
61. Noakes P.S., Holt P.G., Prescott S.L. Maternal smoking in pregnancy alters neonatal cytokine responses. Allergy 2003, 58:1053-1058.
62. Devereux G., Barker R.N., Seaton A. Antenatal determinants of neonatal immune responses to allergens. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 2002, 32:43-50.
63. Tebow G., Sherrill D.L., Lohman I.C., Stern D.A., Wright A.L., Martinez F.D., et al. Effects of parental smoking on interferon gamma production in children. Pediatrics 2008, 121:e1563-e1569.
64. Ng S., Zelikoff J. The effects of prenatal exposure of mice to cigarette smoke on offspring immune parameters. Journal of Toxicology and Environmental Health Part A 2008, 71:445-453.
65. Ng S.P., Silverstone A.E., Lai Z.-W., Zelikoff J.T. Effects of prenatal exposure to cigarette smoke on offspring tumor susceptibility and associated immune mechanisms. Toxicological Sciences 2006, 89:135-144.
66. Singh S.P., Razani-Boroujerdi S., Pena-Philippides J.C., Langley R.J., Mishra N.C., Sopori M.L. Early postnatal exposure to cigarette smoke impairs the antigen-specific T-cell responses in the spleen. Toxicology Letters 2006, 167:231-237.
67. Urso P., Gengozian N. Subnormal expression of cell-mediated and humoral immune responses in progeny disposed toward a high incidence of tumors after in utero exposure to benzo [a] pyrene. Journal of Toxicology and Environmental Health Part A 1984, 14:569-584.
68. Basta P.V., Basham K.B., Ross W.P., Brust M.E., Navarro H.A. Gestational nicotine exposure alone or in combination with ethanol down-modulates offspring immune function. International Journal of Immunopharmacology 2000, 22:159-169.
69. Phaybouth V., Wang S.Z., Hutt J.A., McDonald J.D., Harrod K.S., Barrett E.G. Cigarette smoke suppresses Th1 cytokine production and increases RSV expression in a neonatal model. American Journal of Physiology-Lung Cellular and Molecular Physiology 2006, 290:L222.
70. Chang J.S. Parental smoking and childhood leukemia. Methods in Molecular Biology (Clifton, NJ) 2009, 472:103-137.
71. Sorahan T., Lancashire R.J. Parental cigarette smoking and childhood risks of hepatoblastoma: OSCC data. British Journal of Cancer 2004, 90:1016-1018.
72. Pang D., McNally R., Birch J.M. Parental smoking and childhood cancer: results from the United Kingdom Childhood Cancer Study. British Journal of Cancer 2003, 88:373-381.
73. Magnani C., Pastore G., Luzzatto L., Terracini B. Parental occupation and other environmental factors in the etiology of leukemias and non-Hodgkin's lymphomas in childhood: a case-control study. Tumori 1990, 76:413-419.
74. Brooks D.R., Mucci L.A., Hatch E.E., Cnattingius S. Maternal smoking during pregnancy and risk of brain tumors in the offspring. A prospective study of 1.4 million Swedish births. Cancer Causes & Control: CCC 2004, 15:997-1005.
75. Schüz J, Kaletsch U, Kaatsch P, Meinert R, Michaelis J. Risk factors for pediatric tumors of the central nervous system: results from a German population-based case-control study. Pediatric Blood & Cancer 2001;36:274-82.
76. Filippini G., Farinotti M., Ferrarini M. Active and passive smoking during pregnancy and risk of central nervous system tumours in children. Paediatric and Perinatal Epidemiology 2000, 14:78-84.
77. Filippini G., Farinotti M., Lovicu G., Maisonneuve P., Boyle P. Mothers' active and passive smoking during pregnancy and risk of brain tumours in children. International Journal of Cancer/Journal International du Cancer 1994, 57:769-774.
78. Yu Z., Loehr C.V., Fischer K.A., Louderback M.A., Krueger S.K., Dashwood R.H., et al. In utero exposure of mice to dibenzo[a,l]pyrene produces lymphoma in the offspring: role of the aryl hydrocarbon receptor. Cancer Research 2006, 66:755-762.
79. Dietert R.R., Lee J.E., Hussain I., Piepenbrink M. Developmental immunotoxicology of lead. Toxicology and Applied Pharmacology 2004, 198:86-94.
80. Concha G., Vogler G., Lezcano D., Nermell B., Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicological Sciences: An Official Journal of the Society of Toxicology 1998, 44:185-190.
81. Fangstrom B., Moore S., Nermell B., Kuenstl L., Goessler W., Grander M., et al. Breast-feeding protects against arsenic exposure in Bangladeshi infants. Environmental Health Perspectives 2008, 116:963-969.
82. Raqib R., Ahmed S., Sultana R., Wagatsuma Y., Mondal D., Hoque A.M.W., et al. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicology Letters 2009, 185:197-202.
83. Rahman A., Vahter M., Ekstrom E.-C., Rahman M., Golam Mustafa A.H.M., Wahed M.A., et al. Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh. American Journal of Epidemiology 2007, 165:1389-1396.
84. Rahman M., Vahter M., Sohel N., Yunus M., Wahed M.A., Streatfield P.K., et al. Arsenic exposure and age and sex-specific risk for skin lesions: a population-based case-referent study in Bangladesh. Environmental Health Perspectives 2006, 114:1847-1852.
85. Soto-Pena G., Luna A., Acosta-Saavedra L., Conde-Moo P., Lopez-Carrillo L., Cebrian M., et al. Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. The FASEB Journal 2006, 05.
86. Kozul C., Hampton T., Davey J., Gosse J., Nomikos A., Eisenhauer P., et al. Chronic exposure to arsenic in the drinking water alters the expression of immune response genes in mouse lung. Environmental Health Perspectives 2009, 117:1108-1115.
87. Andrew A., Bernardo V., Warnke L., Davey J., Hampton T., Mason R., et al. Exposure to arsenic at levels found in US drinking water modifies expression in the mouse lung. Toxicological Sciences 2007.
88. Patterson R., Vega L., Trouba K., Bortner C., Germolec D. Arsenic-induced alterations in the contact hypersensitivity response in Balb/c mice. Toxicology and Applied Pharmacology 2004, 198:434-443.
89. Kozul C., Ely K., Enelow R., Hamilton J. Low-dose arsenic compromises the immune response to influenza A infection in vivo. Environmental Health Perspectives 2009, 117:1441-1447.
90. Engel A., Lamm S.H. Arsenic exposure and childhood cancer-a systematic review of the literature. Journal of Environmental Health 2008, 71:12-16.
91. Smith A.H., Marshall G., Yuan Y., Ferreccio C., Liaw J., von Ehrenstein O., et al. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environmental Health Perspectives 2006, 114:1293-1296.
92. Waalkes M.P., Ward J.M., Liu J., Diwan B.A. Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicology and Applied Pharmacology 2003, 186:7-17.
93. Liu J., Xie Y., Merrick B.A., Shen J., Ducharme D.M.K., Collins J., et al. Transplacental arsenic plus postnatal 12-O-teradecanoyl phorbol-13-acetate exposures associated with hepatocarcinogenesis induce similar aberrant gene expression patterns in male and female mouse liver. Toxicology and Applied Pharmacology 2006, 213:216-223.
94. Waalkes M.P., Liu J., Ward J.M., Diwan B.A. Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen. Toxicology and Applied Pharmacology 2006, 215:295-305.
95. Waalkes M.P., Liu J., Ward J.M., Powell D.A., Diwan B.A. Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment. Cancer Research 2006, 66:1337-1345.
96. Chen H., Liu J., Merrick B.A., Waalkes M.P. Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology. Molecular Carcinogenesis 2001, 30:79-87.
97. Reichard J.F., Schnekenburger M., Puga A. Long term low-dose arsenic exposure induces loss of DNA methylation. Biochemical and Biophysical Research Communications 2007, 352:188-192.
98. Shen J., Liu J., Xie Y., Diwan B.A., Waalkes M.P. Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure. Toxicological Sciences 2007, 95:313-320.
99. Waalkes M., Liu J., Chen H., Xie Y., Achanzar W., Zhou Y., et al. Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. JNCI Journal of the National Cancer Institute 2004, 96:466.
100. Liu J., Xie Y., Cooper R., Ducharme D.M.K., Tennant R., Diwan B.A., et al. Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism. Toxicology and Applied Pharmacology 2007, 220:284-291.
101. US Environmental Protection Agency. Pesticides industry sales and usage: 2000 and 2001 market estimates. 2004. http://www.epa.gov/oppbead1/pestsales/.
102. Bradman A., Barr D.B., Claus Henn B.G., Drumheller T., Curry C., Eskenazi B. Measurement of pesticides and other toxicants in amniotic fluid as a potential biomarker of prenatal exposure: a validation study. Environmental Health Perspectives 2003, 111:1779-1782.
103. Rowe A.M., Brundage K.M., Barnett J.B. Developmental immunotoxicity of atrazine in rodents. Basic & Clinical Pharmacology & Toxicology 2008, 102:139-145.
104. Rooney A.A., Matulka R.A., Luebke R.W. Developmental atrazine exposure suppresses immune function in male, but not female Sprague-Dawley rats. Toxicological Sciences 2003, 76:366-375.
105. Theus S.A., Tabor D.R., Soderberg L.S., Barnett J.B. Macrophage tumoricidal mechanisms are selectively altered by prenatal chlordane exposure. Agents and Actions 1992, 37:140-146.
106. Blaylock B.L., Soderberg L.S., Gandy J., Menna J.H., Denton R., Barnett J.B. Cytotoxic T-lymphocyte and NK responses in mice treated prenatally with chlordane. Toxicology Letters 1990, 51:41-49.
107. Barnett J.B., Holcomb D., Menna J.H., Soderberg L.S. The effect of prenatal chlordane exposure on specific anti-influenza cell-mediated immunity. Toxicology Letters 1985, 25:229-238.
108. Barnett J.B., Soderberg L.S., Menna J.H. The effect of prenatal chlordane exposure on the delayed hypersensitivity response of BALB/c mice. Toxicology Letters 1985, 25:173-183.
109. Menna J.H., Barnett J.B., Soderberg L.S. Influenza type A virus infection of mice exposed in utero to chlordane; survival and antibody studies. Toxicology Letters 1985, 24:45-52.
110. Turner M.C., Wigle D., Krewski D. Residential pesticides and childhood leukemia: a systematic review and meta-analysis. Environmental Health Perspectives 2010, 118:33-41.
111. Wigle D.T., Turner M.C., Krewski D. A systematic review and meta-analysis of childhood leukemia and parental occupational pesticide exposure. Environmental Health Perspectives 2009, 117:1505-1513.
112. Zahm S.H., Ward M.H. Pesticides and childhood cancer. Environmental Health Perspectives 1998, 106:893.
113. Infante-Rivard C., Weichenthal S. Pesticides and childhood cancer: an update of Zahm and Ward's 1998 review. Journal of Toxicology and Environmental Health Part B: Critical Reviews, 10 2007, 1:81-99.
114. Peden-Adams M., Keller J., EuDaly J., Berger J., Gilkeson G., Keil D. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate (PFOS). Toxicological Sciences 2008.
115. Peden-Adams M., EuDaly J., Dabra S., EuDaly A., Heesemann L., Smythe J., et al. Suppression of humoral immunity following exposure to the perfluorinated insecticide sulfluramid. Journal of Toxicology and Environmental Health Part A 2007, 70:1130-1141.
116. Keil D.E., Mehlmann T., Butterworth L., Peden-Adams M.M. Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice. Toxicological Sciences 2008, 103:77-85.
117. McKinney P.A., Raji O.Y., van Tongeren M., Feltbower R.G. The UK Childhood Cancer Study: maternal occupational exposures and childhood leukaemia and lymphoma. Radiation Protection Dosimetry 2008, 132:232-240.
118. Sung T.-I., Wang J.-D., Chen P.-C. Increased risk of cancer in the offspring of female electronics workers. Reproductive Toxicology 2008, 25:115-119.
119. Colt J.S., Blair A. Parental occupational exposures and risk of childhood cancer. Environmental Health Perspectives 1998, 106(Suppl 3):909-925.
120. Savitz D.A., Chen J.H. Parental occupation and childhood cancer: review of epidemiologic studies. Environmental Health Perspectives 1990, 88:325-337.
121. Buckley J.D., Robison L.L., Swotinsky R., Garabrant D.H., LeBeau M., Manchester P., et al. Occupational exposures of parents of children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study Group. Cancer Research 1989, 49:4030-4037.
122. Infante-Rivard C., Siemiatycki J., Lakhani R., Nadon L. Maternal exposure to occupational solvents and childhood leukemia. Environmental Health Perspectives 2005, 113:787-792.
123. Yamamoto S., Tin Tin Win S., Yoshida Y., Kunugita N., Arashidani K., Fujimaki H. Children's immunology, what can we learn from animal studies (2): modulation of systemic Th1/Th2 immune response in infant mice after prenatal exposure to low-level toluene and toll-like receptor (TLR) 2 ligand. The Journal of Toxicological Sciences 2009, 34(Suppl 2):SP341-SP348.
124. Blossom S.J., Doss J.C. Trichloroethylene alters central and peripheral immune function in autoimmune-prone MRL(+/+) mice following continuous developmental and early life exposure. Journal of Immunotoxicology 2007, 4:129-141.
125. Blossom S.J., Doss J.C., Hennings L.J., Jernigan S., Melnyk S., James S.J. Developmental exposure to trichloroethylene promotes CD4+ T cell differentiation and hyperactivity in association with oxidative stress and neurobehavioral deficits in MRL+/+ mice. Toxicology and Applied Pharmacology 2008, 231:344-353.
126. Peden-Adams M., Eudaly J., Heesemann L., Smythe J., Miller J., Gilkeson G., et al. Developmental immunotoxicity of trichloroethylene (TCE): studies in B6C3F1 mice. Journal of Environmental Science and Health Part A 2006, 41:249-271.
127. Calafat A.M., Ye X., Wong L.Y., Reidy J.A., Needham L.L. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environmental Health Perspectives 2008, 116:39-44.
128. Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, Brock JW, et al. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000.
129. Inoue K., Kato K., Yoshimura Y., Makino T., Nakazawa H. Determination of bisphenol A in human serum by high-performance liquid chromatography with multi-electrode electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications 2000, 749:17-23.
130. Silva M.J., Reidy J.A., Herbert A.R., Preau J.L., Needham L.L., Calafat A.M. Detection of phthalate metabolites in human amniotic fluid. Bulletin of Environmental Contamination and Toxicology 2004, 72:1226-1231.
131. Piepenbrink M.S., Hussain I., Marsh J.A., Dietert R.R. Developmental immunotoxicology of di-(2-ethylhexyl)phthalate (DEHP): age-based assessment in the female rat. Journal of Immunotoxicology 2005, 2:21-31.
132. Kimber I., Dearman R.J. An assessment of the ability of phthalates to influence immune and allergic responses. Toxicology 2010, 271:73-82.
133. Yan H., Takamoto M., Sugane K. Exposure to Bisphenol A prenatally or in adulthood promotes T(H)2 cytokine production associated with reduction of CD4CD25 regulatory T cells. Environmental Health Perspectives 2008, 116:514-519.
134. Yoshino S., Yamaki K., Li X., Sai T., Yanagisawa R., Takano H., et al. Prenatal exposure to bisphenol A up-regulates immune responses, including T helper 1 and T helper 2 responses, in mice. Immunology 2004, 112:489-495.
135. Ohshima Y., Yamada A., Tokuriki S., Yasutomi M., Omata N., Mayumi M. Transmaternal exposure to bisphenol a modulates the development of oral tolerance. Pediatrics Research 2007, 62:60-64.
136. Midoro-Horiuti T, Tiwari R, Watson CS, Goldblum RM. Maternal bisphenol a exposure promotes the development of experimental asthma in mouse pups. Environmental Health Perspectives 2010;118:273-7.
137. Alizadeh M., Ota F., Hosoi K., Kato M., Sakai T., Satter M.A. Altered allergic cytokine and antibody response in mice treated with Bisphenol A. Journal of Medical Investigation 2006, 53:70-80.
138. Sawai C., Anderson K., Walser-Kuntz D. Effect of bisphenol A on murine immune function: modulation of interferon-gamma, IgG2a, and disease symptoms in NZB X NZW F1 mice. Environmental Health Perspectives 2003, 111:1883-1887.
139. Goto M., Takano-Ishikawa Y., Ono H., Yoshida M., Yamaki K., Shinmoto H. Orally administered bisphenol A disturbed antigen specific immunoresponses in the naive condition. Bioscience, Biotechnology and Biochemistry 2007, 71:2136-2143.
140. Yurino H., Ishikawa S., Sato T., Akadegawa K., Ito T., Ueha S., et al. Endocrine disruptors (environmental estrogens) enhance autoantibody production by B1 cells. Toxicological Sciences 2004, 81:139-147.
141. Skinner M.K., Manikkam M., Guerrero-Bosagna C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends in Endocrinology Metabolism 2010, 21:214-222.
142. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genetics 2003, 33(Suppl.):245-254.
143. Anway M.D., Cupp A.S., Uzumcu M., Skinner M.K. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science (New York, NY) 2005, 308:1466-1469.
144. Dolinoy D.C., Huang D., Jirtle R.L. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proceeding of the National Academy Sciences of the USA 2007, 104:13056-13061.
145. Yaoi T., Itoh K., Nakamura K., Ogi H., Fujiwara Y., Fushiki S. Genome-wide analysis of epigenomic alterations in fetal mouse forebrain after exposure to low doses of bisphenol A. Biochemical and Biophysical Research Communications 2008, 376:563-567.
146. Bromer J.G., Zhou Y., Taylor M.B., Doherty L., Taylor H.S. Bisphenol-a exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. Federation of American Societies for Experimental Biology 2010, 24:2273-2280.
147. Prins G.S., Tang W.Y., Belmonte J., Ho S.M. Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis. Basic & Clinical Pharmacology & Toxicology 2008, 102:134-138.
148. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute. President's cancer panel: reducing environmental cancer risk. 2008-2009 Annual Report. http://deainfo.nci.nih.gov/advisory/pcp/pcp.htm.
149. Bellinger D.L., Lubahn C., Lorton D. Maternal and early life stress effects on immune function: relevance to immunotoxicology. Journal of Immunotoxicology 2008, 5:419-444.
150. Collins FS. Research agenda. Opportunities for research and NIH. Science 2010;327:36-7.